3C Patch for treating diabetic foot ulcers (MTG66)Product type:GuidanceProgramme:Medical technologies guidancePublished: 7 March 2022
Diabetes (type 1 and type 2) in children and young people: diagnosis and management – periodontal diseaseStatus:In developmentProgramme:NICE guidelineExpected publication date: 29 June 2022
Type 1 diabetes in adults: diagnosis and management – periodontal diseaseStatus:In developmentProgramme:NICE guidelineExpected publication date: 29 June 2022
Type 2 diabetes in adults: management - periodontal diseaseStatus:In developmentProgramme:NICE guidelineExpected publication date: 29 June 2022
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 6 June 2022Expected publication date: 14 September 2022
Dexamethasone intravitreal implant for treating diabetic macular oedema in people without a pseudophakic lens [ID3951]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: 14 September 2022
Brolucizumab for treating diabetic macular oedema [ID3902]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 16 November 2022
Diabetic foot problems: prevention and management (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 18 January 2023
Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 3 January 2024
Diabetic retinopathyStatus:In developmentProgramme:NICE guidelineExpected publication date: 3 April 2024
Faricimab for treating diabetic macular oedema [ID3899]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tirzepatide for treating type 2 diabetes ID3938Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesStatus:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition TS ID 10753Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Type 2 diabetes in adults: management (medicines update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC